JP2019503356A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019503356A5 JP2019503356A5 JP2018532435A JP2018532435A JP2019503356A5 JP 2019503356 A5 JP2019503356 A5 JP 2019503356A5 JP 2018532435 A JP2018532435 A JP 2018532435A JP 2018532435 A JP2018532435 A JP 2018532435A JP 2019503356 A5 JP2019503356 A5 JP 2019503356A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally
- formula
- alkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022078995A JP7458681B2 (ja) | 2015-12-22 | 2022-05-12 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
| JP2024041282A JP2024073581A (ja) | 2015-12-22 | 2024-03-15 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015905333A AU2015905333A0 (en) | 2015-12-22 | Modulators of Endosomal G Protein-Coupled Receptors | |
| AU2015905333 | 2015-12-22 | ||
| US201662291161P | 2016-02-04 | 2016-02-04 | |
| US62/291,161 | 2016-02-04 | ||
| PCT/US2016/068075 WO2017112792A1 (en) | 2015-12-22 | 2016-12-21 | Tripartite modulators of endosomal g protein-coupled receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078995A Division JP7458681B2 (ja) | 2015-12-22 | 2022-05-12 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019503356A JP2019503356A (ja) | 2019-02-07 |
| JP2019503356A5 true JP2019503356A5 (https=) | 2020-02-06 |
| JP7074673B2 JP7074673B2 (ja) | 2022-05-24 |
Family
ID=59091175
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532435A Active JP7074673B2 (ja) | 2015-12-22 | 2016-12-21 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
| JP2022078995A Active JP7458681B2 (ja) | 2015-12-22 | 2022-05-12 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
| JP2024041282A Pending JP2024073581A (ja) | 2015-12-22 | 2024-03-15 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078995A Active JP7458681B2 (ja) | 2015-12-22 | 2022-05-12 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
| JP2024041282A Pending JP2024073581A (ja) | 2015-12-22 | 2024-03-15 | エンドソーマルｇタンパク質共役受容体のトリパータイト・モジュレーター |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11324832B2 (https=) |
| EP (1) | EP3393519A1 (https=) |
| JP (3) | JP7074673B2 (https=) |
| CN (2) | CN108712913B (https=) |
| AU (3) | AU2016377658B2 (https=) |
| CA (1) | CA3009325A1 (https=) |
| EA (1) | EA201891472A1 (https=) |
| WO (1) | WO2017112792A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2978736C (en) | 2015-03-04 | 2023-11-07 | Vanda Pharmaceuticals Inc. | Dosing regimen of tradipitant |
| WO2017112792A1 (en) * | 2015-12-22 | 2017-06-29 | Takeda Pharmaceutical Company Limited | Tripartite modulators of endosomal g protein-coupled receptors |
| CN109152777A (zh) * | 2016-05-20 | 2019-01-04 | 武田药品工业株式会社 | 疼痛的治疗 |
| KR20250140655A (ko) * | 2017-11-17 | 2025-09-25 | 반다 파마슈티칼즈, 인코퍼레이티드. | 트라디피탄트를 이용한 위장 질환의 치료 방법 |
| IT202200018780A1 (it) * | 2022-09-14 | 2024-03-14 | Alberto Chiarugi | Modulatori degli effetti della chemioterapia |
| IT202200018768A1 (it) * | 2022-09-14 | 2024-03-14 | Alberto Chiarugi | Trattamento della nausea e vomito da chemioterapia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1394150B1 (en) | 1999-02-24 | 2011-01-19 | F. Hoffmann-La Roche AG | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| SI1157005T1 (en) | 1999-02-24 | 2005-02-28 | F. Hoffmann-La Roche Ag | 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists |
| US7696168B2 (en) * | 2000-04-21 | 2010-04-13 | Tufts Medical Center, Inc. | G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| TWI287003B (en) | 2000-07-24 | 2007-09-21 | Hoffmann La Roche | 4-phenyl-pyridine derivatives |
| TWI259180B (en) | 2000-08-08 | 2006-08-01 | Hoffmann La Roche | 4-Phenyl-pyridine derivatives |
| EP2119455A1 (en) * | 2004-04-08 | 2009-11-18 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tripartite raftophilic structures and their use |
| NZ551563A (en) | 2004-06-30 | 2009-06-26 | Janssen Pharmaceutica Nv | Alpha,beta-unsaturated esters and acids by stereoselective dehydration |
| TW200606152A (en) | 2004-07-02 | 2006-02-16 | Tanabe Seiyaku Co | Piperidine compound and process for preparing the same |
| JP2013542929A (ja) * | 2010-09-28 | 2013-11-28 | パナセア バイオテック リミテッド | 新規ビシクロ環化合物 |
| WO2014168721A2 (en) * | 2013-04-12 | 2014-10-16 | Tufts Medical Center | Methods and systems for designing and/or characterizing soluble lipidated ligand agents |
| JP6427491B2 (ja) | 2013-07-03 | 2018-11-21 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2017112792A1 (en) * | 2015-12-22 | 2017-06-29 | Takeda Pharmaceutical Company Limited | Tripartite modulators of endosomal g protein-coupled receptors |
-
2016
- 2016-12-21 WO PCT/US2016/068075 patent/WO2017112792A1/en not_active Ceased
- 2016-12-21 CA CA3009325A patent/CA3009325A1/en active Pending
- 2016-12-21 JP JP2018532435A patent/JP7074673B2/ja active Active
- 2016-12-21 EP EP16831867.3A patent/EP3393519A1/en active Pending
- 2016-12-21 EA EA201891472A patent/EA201891472A1/ru unknown
- 2016-12-21 AU AU2016377658A patent/AU2016377658B2/en active Active
- 2016-12-21 US US16/064,061 patent/US11324832B2/en active Active
- 2016-12-21 CN CN201680074910.1A patent/CN108712913B/zh active Active
- 2016-12-21 CN CN202210637197.4A patent/CN115531553A/zh active Pending
-
2022
- 2022-05-06 US US17/738,739 patent/US20230119819A1/en not_active Abandoned
- 2022-05-12 JP JP2022078995A patent/JP7458681B2/ja active Active
- 2022-12-28 AU AU2022291659A patent/AU2022291659A1/en not_active Abandoned
-
2024
- 2024-03-15 JP JP2024041282A patent/JP2024073581A/ja active Pending
- 2024-09-03 US US18/823,317 patent/US20250235544A1/en active Pending
-
2025
- 2025-02-18 AU AU2025201136A patent/AU2025201136A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019503356A5 (https=) | ||
| JP2010521485A5 (https=) | ||
| ES2777626T3 (es) | Sulfonilureas y compuestos relacionados y uso de los mismos | |
| HRP20130900T1 (hr) | Derivat (aza)indola i njegova uporaba u medicinske svrhe | |
| ES2615481T3 (es) | Antagonistas de glucagón | |
| JP2008513496A5 (https=) | ||
| UY33605A (es) | Profarmacos que comprenden un conjugado de conector de exendina | |
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| JP2012509846A5 (https=) | ||
| EA201000157A1 (ru) | Неосновные антагонисты рецептора меланин-концентрирующего гормона 1 типа и их применение | |
| MX2012001399A (es) | Profarmacos que comprenden un conjugado de insulina-conector. | |
| BRPI0515372B8 (pt) | composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico | |
| EP2423207A3 (en) | 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors | |
| EA201100698A1 (ru) | Производные тиенотриазолодиазепина, активные в отношении апо а1 | |
| JP2008195730A5 (https=) | ||
| EA200970287A1 (ru) | Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты | |
| JP2013503862A5 (https=) | ||
| JP2013533253A5 (https=) | ||
| JP2013540114A5 (https=) | ||
| JP2011517453A5 (https=) | ||
| EP2682387A3 (en) | C7-fluoro substituted tetracycline compounds | |
| RU2008152763A (ru) | Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии | |
| PE20210176A1 (es) | Inhibidores de arginasa y sus metodos de uso | |
| ATE520651T1 (de) | Substituierte phenylmethylbicyclocarbonsäureamidverbindungen | |
| CO6430439A2 (es) | Agonistas del receptor de esfingosina -1- fosfato |